Degree in Anestheisa and Critical Care, University Hospital of Nantes, France. Evaluation of global longitudinal strain woth speckle-tracking echigraphy in SAH and TBI. Post-doc research year at University Hospital of Lariboisière (Prof. Alexandre Mebazaa).

Current recent topics: mechanical ventilation in neuro-critical care, post-critical care syndrome.

University of Nantes, Nantes, France

Emeritus Professor of Neurosurgery at the Antwerp University Hospital and University of Antwerp. He holds positions as past Chairman of the Neurotraumatology Committee of the World Federation of Neurosurgical Societies (WFNS) and the International Neurotrauma Society, and is Co-Chairman of the European Brain Injury Consortium. He has a vast experience as a general neurosurgeon and has specific research interests in Traumatic Brain Injury and neuro-intensive care.

Dr Maas was the Principal Investigator of the IMPACT study group (International Mission on Prognosis and Clinical Trial design in TBI), that was awarded an NIH grant (2003-2011) and resulted in over 55 publications and recommendations for improved trial design. Currently, together with Prof David Menon, University of Cambridge, he coordinates the large scale collaborative project CENTER-TBI: Collaborative European NeuroTrauma Effectiveness Research in TBI (www.center-tbi.eu), supported by the FP7 program of the European Union (Grant no: 602150; duration:2013-2020). He received an Honorary doctoral degree at the Burdenko Institute of Neurosurgery in Moscow in 2013 and Lifetime Achievement Award for his work on traumatic brain injury from the International Brain Injury Association in 2016.

Department of Neurosurgery, Antwerp University Hospital and University of Antwerp, Edegem, Belgium.

He studied Medicine at the Vrije Universiteit, Amsterdam (1994) and worked subsequently as a resident in Neurology in Sint Lucas Hospital, Amsterdam (1994). He was research fellow in Neuro-Epidemiology at the G.H. Sergievsky Center, Columbia University, New York (1996), and received a PhD in Epidemiology from Erasmus University, Rotterdam (1998), on a thesis on dementia. During his residency in Neurology at UMC Utrecht (1999-2004), he became enthusiastic for Neurocritical Care. After a fellowship in Intensive Care Medicine (AMC Amsterdam, 2004-2006), he rejoined UMC Utrecht where he is currently working as a consultant neurologist-intensivist at the Department of Intensive Care Medicine. He is further chair of the Dutch Working Group Neuro-Intensive Care. In 2016, he was appointed as Professor in Intensive Care Neuropsychiatry at Utrecht University. Dr Slooter was chair of the latest delirium guidelines committee of the (American) Society of Critical Care Medicine (SCCM), as well as initiator and chair of an international consortium to update nomenclature on delirium and acute encephalopathy that was endorsed by numerous medical societies. Since 2018 he is President of the European Delirium Association.

The research focus of Arjen Slooter is on delirium and on neuropsychiatric outcome after anesthesia/surgery or critical illness. Using various methods and approaches (epidemiology, EEG, MRI), he has investigated all aspects of delirium, including its phenomenology and brain network characteristics, detection and monitoring, risk factors, prognosis, prevention and treatment. Research on neuropsychiatric outcomes includes risk factor analysis on cognitive decline, mental illness and chronic pain after critical illness and treatment in the ICU.

The clinical focus of Arjen Slooter is on Intensive Care of neurological- and neurosurgical patients, and on neurological complications of critical illness. He is responsible for training of ICU nurses, residents and fellows in Neuro-Intensive Care in the UMC Utrecht.

Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.